Affected by factors such as the aging of the population and the increase in the proportion of residents, China’s medical expenditures continue to increase, which is a rigid demand; at the same time, with the continuous improvement of people’s health standards and the development of Internet medical technology, China’s big health industry will continue to maintain growth for a long period of time.
Comparison of medical expenditure data between China and major countries in the world
The data shows that the US, Switzerland, Germany, France and other developed countries in Europe and the United States generally account for more than 10% of GDP in medical and health expenditures. The OECD countries average 8.8%. China currently only accounts for 6.6%, which still has a big space for improvement. As China becomes an important economy in the world, China’s industrial structure and medical development will gradually approach the United States, Germany, etc., so China’s medical expenditure still has a lot of room for growth.
Big data monitoring of the revenue scale of China’s big health industry
From 2014 to 2020, the overall revenue of China’s health industry continued to grow. In 2020, the revenue exceeded 7 trillion yuan, and it is expected to reach 8 trillion yuan in 2021, an increase of 8.1%. The development of the health industry in China and the world is basically the same, and the demand is also increasing due to changes in the social structure, with sustainable growth.
Big data monitoring of income status of China’s big health industry segments
Thanks to the development of the big health industry and the increase in demand for medicines during the pandemic, major health segments such as pharmaceutical manufacturing and medical devices have performed well. According to data from iiMedia Research, in 2020, China’s pharmaceutical manufacturing investment income reached 34.41 billion yuan, an increase of 27.6% year-on-year; the market size of China’s medical device industry exceeded 700 billion yuan, an increase of 16.8% year-on-year.
Big Data Monitoring of Capital Attraction in China’s Big Health Industry
The study found that the new economy industry with the highest investment enthusiasm in China in 2020 was medical and health. Among the hot investment fields, biopharmaceuticals had the highest investment amount, exceeding 90 billion yuan. In addition, medical devices in the broad health segment have also won 27.3 billion yuan in transaction volume. It can be seen that under the pandemic, the financing enthusiasm in the health industry of China is still high.
Source: iiMedia Consulting